27-02-2023, 19:35

Zevra Therapeutics to Report Fourth Quarter and Full-Year

CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company,
Globe Newswire27-02-2023, 19:35
24-02-2023, 19:35

Zevra Therapeutics Announces Arimoclomol Research Featured

Interim data analysis of four-year, open-label extension from Phase 2/3 clinical trial suggests arimoclomol may reduce
Globe Newswire24-02-2023, 19:35
22-02-2023, 20:53

CORRECTION – KemPharm Announces Corporate Name Change to

New name, Greek for “zebra,” is the internationally-recognized symbol for the rare disease community Branding reflects
Globe Newswire22-02-2023, 20:53
31-01-2023, 19:35

KemPharm Enhances Senior Management Team

Daniel Gallo, Ph.D., Appointed Senior Vice President of Medical Affairs and Advocacy Abbi Maher, J.D., Named Vice
Globe Newswire31-01-2023, 19:35